On Monday, the US Food and Drugs Administration warned that the Johnson & Johnson (Janssen) vaccine could cause a rare. FDA observed an increase in reports of a rare paralyzing condition called the Guillain-Barre syndrome.
“Guillain Barre syndrome (a neurological disorder in which the body’s immune system damages nerve cells, causing muscle weakness and sometimes paralysis) has occurred in some people who have received the Janssen COVID-19 Vaccine,” the FDA said in its label update.
The FDA further said that out of 12.8 million Johnson vaccines administered, as many as 100 preceding GBS had been registered with the US Vaccine Adverse Reporting System.
FDA further said that people should immediately seek medical attention if symptoms such as weakness or tingling in the arms and legs. Other symptoms doing the rounds include difficulty in walking, speaking, chewing or swallowing, double vision, bowel or bladder control problems.
However, the FDA, informed that the Moderna, Pfizer and BioNTech Covid-19 vaccines do not show any such issue.
